ANCA testing: where are we now?

Intern Emerg Med. 2021 Mar;16(2):269-271. doi: 10.1007/s11739-020-02584-w. Epub 2021 Jan 1.

Authors

Milena Bond^#¹, Filippo Fagni^#², Augusto Vaglio³

Affiliations

¹ Department of Medicine, Rheumatology Clinic, S. Chiara Hospital, Trento, Italy.
² Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
³ Nephrology and Dialysis Unit, Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", Meyer Children's Hospital, University of Firenze, Viale Pieraccini 6, 50139, Florence, Italy. [email protected].

^# Contributed equally.

PMID: 33385295
DOI: 10.1007/s11739-020-02584-w

No abstract available

Publication types

Comment

MeSH terms

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / diagnosis
Antibodies, Antineutrophil Cytoplasmic*
Hospitals
Humans

Substances

Antibodies, Antineutrophil Cytoplasmic